The 'Targeting Drugs to the Brain' project aims to develop a platform to find nanobody constructs that can cross the blood-brain barrier, as a way of treating brain diseases.
Developing a platform to find nanobody constructs that can cross the blood-brain barrier, as a way of treating brain diseases in the blood-brain-barrier (BBB) project.